medical research foundation trinidad port of spain

Welcome to the Medical Research Foundation

• Schedule of Planned Procurement 2024
• Phone: (868) 623-5834
• Email: [email protected]

Our Location

7 Queens Park East Port of Spain Trinidad & Tobago

(868) 623-5834 (868) 625-8512 (868) 627-9923

7 Queens Park East Port of Spain Trinidad & Tobago​

Opening Hours

Monday and Friday 6:30am – 2:30pm

• Vaccination Programme
• Appointments
• Health Topics
• Testimonials
• Volunteering
• Patient Testimonials
• Staff Testimonials

Researchers

• Support MRF
• Mission & Vision

Sign up for our emails

Copyright © 2024 Medical Research Foundation of Trinidad & Tobago.

• Privacy Policy
• Terms of Use
• Make an Appointment
• Adolescents’ Clinic
• Women’s Health Check-up
• Men’s Clinic
• Prisons Clinic
• Evening Clinic
• Vaccines Program
• Telemedicine
• Partner Testing

HIV Counselling And Testing Sites

Know your status – get tested.

Trinidad and Tobago has many accomplishments in our response to the Human Immunodeficiency Virus (HIV). Currently, the Ministry of Health is executing the Joint United Nations Programme on HIV/AIDS “95-95-95” targets which state by 2025, or 95% of people who are living with HIV to know their HIV status, 95% of people who know that they are living with HIV to be on lifesaving antiretroviral treatment, and 95% of people who are on treatment to be virally suppressed. We promote the Undetectable= Untransmittable (U=U) messaging that indicates someone with an undetectable HIV viral load on HIV treatment (ART) cannot transmit HIV. In keeping with this momentum, the Ministry of Health would like to remind citizens to refrain from engaging in risky sexual behaviour that would put one at risk of becoming HIV infected. Sexual and reproductive health involves making safe choices to protect oneself and your partner every day. Taking an HIV test is one of the safe choices a person can make. Despite this reality, there are a number of nationals who have never taken the HIV test to date. The sooner a person knows his/her status, the sooner he can access treatment (if found to be positive) thus increasing the chance of preventing other health conditions from developing.

So remember:

• Regardless of whom a person is or what he does, all are welcome to access the HIV test free from discrimination. Confidential service is offered, as well as pre and post counselling (before and after the test) to reduce risk if a person is negative, and offer support and referral to treatment if a person is positive.
• The Ministry of Health offers free same-day HIV testing at fifty-two (52) sites collectively nationwide five days a week, twelve months a year.
• Condoms are available at all testing sites.
• With advances in HIV rapid testing technology, it takes just one drop of blood to determine a person’s HIV status and results are given in as little as 20 minutes.
• Upon receiving the results of the test, whether negative or positive, standard follow up measures including counselling is offered at all testing sites.

Eastern Regional Health Authority

North central regional health authority, north west regional health authority, south west regional health authority, tobago regional health authority.

• Sexual Health Services

• Trinidad and Tobago
• Civil Society
• Facts & Figures
• Document Centre

Our Partners

Trinidad and tobago partners.

• All member countries
• Our network:
• Commonwealth Education Online
• Commonwealth Governance Online
• Commonwealth Health Online

Description

• New Contract Awards
• New Grant Awards

The Medical Research Foundation Of Trinidad And Tobago

Show quick stats (see federal award analysis for full details), federal award analysis scope: data includes non-classified prime contracts and grants reported by the government and subcontracts and subgrants as reported by prime awardees. adjustments are made to aggregate related awardees, remove likely erroneous data, and to assign classifications. timing: data is typically available within 30 days of award except for the department of defense, which is typically delayed 90 days. data is presented as of the date of obligation. aggregation: for acquired subsidiaries, data is presented on a pro forma 'past performance' basis from the date of the acquired awardees' formation. years: gfy ending september 30. ">, the medical research foundation of trinidad and tobago federal award history.

• Vehicle Rankings
• Awardee Rankings

Subcontracts

• Awarding Agency
• Funding Agency
• Awarding Sub-Agency
• Funding Sub-Agency
• Defense Program
• Extent Competed
• # of Bidders
• Pricing Type
• Vehicle Type
• Grant Program
• Filtered Records

Federal Registration and Certifications

Vendor contacts at the medical research foundation of trinidad and tobago, visible records, all records, grant awards, the medical research foundation of trinidad and tobago direct grants, subgrant awards, the medical research foundation of trinidad and tobago subgrant awards, teaming partners, disclosed awardee sub and prime contract and grant relationships.

HIV/AIDS Prevention and Treatment in Trinidad and Tobago Bartholomew, Courtenay    Medical Research Fdn of Trinidad/Tobago, Port-of-Spain, Trinidad/Toba

• Institution
• Related projects

 Recent in Grantomics:

• Your institution vs. funders. Who wins? Read more...
• How should you pick the next fundable research topic? Read more...

 Recently viewed grants:

• Outcomes of non-vitamin K anticoagulants in atrial fibrillation
• Alternative mechanisms of signaling via trimeric G proteins
• Molecular Analysis of Effector and Regulatory T cell Responses in MS
• Alcoholism and Schizophrenia - Effects of Clozapine
• Regulation of Skeletal Muscle Metabolism

 Recently added grants:

• Measurement of Individualized Factors Associated with Tinnitus Burden
• Folding and chaperone interactions of multi-domain proteins
• RNA Toxicity and Muscle Regeneration
• Epigenetic regulation by tumor suppressor p53
• Learning and brain plasticity in children with autism: relation to cognitive inflexibility and restricted-repetitive behaviors

  Abstract

The applicant organization, the Medical Research Foundation of Trinidad and Tobago (MRFTT), has been conducting retroviral research for the past 17 years and is currently one of the HVTN sites conducting a Phase II HIV vaccine trial (HIVNET 026). The overall aim of this project is to conduct HIV/AIDS prevention and treatment intervention studies to fill the gaps in available knowledge and to provide scientific and public health solutions to the HIV epidemic in Trinidad and Tobago, a middle-income developing country. Our hypothesis is that the Trinidad & Tobago share attributes with many countries in the Caribbean region and world that make such knowledge applicable to these countries. The major aim of this RO3 submission is to develop a research program responsive to the research needs of the HIV/AIDS epidemic in Trinidad and Tobago and to the CIPRA process. During the execution period there will be a comprehensive assessment of the site development needs, site infrastructure and critical clinical and laboratory capacity to perform relevant HIV/AIDS prevention and treatment intervention research, including clinical trials. The final CIPRA cooperative agreement application will be developed and submitted during this period. The MRF1T has throughout its years of research established collaborations locally, regionally and internationally and during the RO3 period these collaborations will be further strengthened. The Caribbean Epidemiology Center (CAREC) has been a research and implementation partner since 1984, and laboratory support for the majority of the studies conducted here has resided at CAREC. CAREC also provides the opportunity to disseminate the findings of these intervention studies to the wider Caribbean. The MRF1T has conducted all studies with the cooperation and collaboration of the Ministry of Health (MOH), and through the CIPRA application, the MRFTT will further enhance its relationship with the MOH in meeting the challenges of the HIV/AIDS epidemic in Trinidad and Tobago and in the development of appropriate prevention and treatment intervention public health programs. The MRF1T will also draw on its ties to local NGO's and its international collaborations with the Institute of Human Virology of the University of Maryland, Baltimore and Duke University, North Carolina in the development and conduct of the planned research.

  Funding Agency

  institution,   related projects,   comments.

Prevalence and risk factors for sexually transmitted infections among people living with HIV attending a sexually transmitted infection clinic in Trinidad

Affiliations.

• 1 Medical Research Foundation of Trinidad and Tobago, Port of Spain, Trinidad.
• 2 Department of Paraclinical Sciences, University of the West Indies, St Augustine, Trinidad.
• 3 Department of Community Health and Psychiatry, University of the West Indies, Kingston, Jamaica.
• PMID: 31558127
• DOI: 10.1177/0956462419863536

Keywords: Sexually transmitted infection prevalence; people living with HIV; syphilis.

• Coinfection / epidemiology*
• Cross-Sectional Studies
• HIV Infections / complications
• HIV Infections / epidemiology*
• HIV Infections / transmission
• Middle Aged
• Risk Factors
• Sex Factors
• Sexual Behavior / statistics & numerical data*
• Sexual Partners
• Sexually Transmitted Diseases / complications
• Sexually Transmitted Diseases / epidemiology*
• Surveys and Questionnaires
• Syphilis / epidemiology
• Trinidad and Tobago / epidemiology
• Young Adult